• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰国家数字审查小组中胃肠道病理学家在 Barrett 食管中的表现:80 例前瞻性活检审查结果。

Performance of gastrointestinal pathologists within a national digital review panel for Barrett's oesophagus in the Netherlands: results of 80 prospective biopsy reviews.

机构信息

Department of Gastroenterology and Hepatology, Amsterdam UMC - Locatie AMC, Amsterdam, The Netherlands

Department of Gastroenterology and Hepatology, Amsterdam UMC - Locatie AMC, Amsterdam, The Netherlands.

出版信息

J Clin Pathol. 2021 Jan;74(1):48-52. doi: 10.1136/jclinpath-2020-206511. Epub 2020 May 28.

DOI:10.1136/jclinpath-2020-206511
PMID:32467320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7788478/
Abstract

AIMS

The histopathological diagnosis of low-grade dysplasia (LGD) in Barrett's oesophagus (BO) is associated with poor interobserver agreement and guidelines dictate expert review. To facilitate nationwide expert review in the Netherlands, a web-based digital review panel has been set up, which currently consists of eight 'core' pathologists. The aim of this study was to evaluate if other pathologists from the Dutch BO expert centres qualify for the expert panel by assessing their performance in 80 consecutive LGD reviews submitted to the panel.

METHODS

Pathologists independently assessed digital slides in two phases. Both phases consisted of 40 cases, with a group discussion after phase I. For all cases, a previous consensus diagnosis made by five core pathologists was available, which was used as reference. The following criteria were used: (1) percentage of 'indefinite for dysplasia' diagnoses, (2) percentage agreement with consensus diagnosis and (3) proportion of cases with a consensus diagnosis of dysplasia underdiagnosed as non-dysplastic. Benchmarks were based on scores of the core pathologists.

RESULTS

After phase I, 1/7 pathologists met the benchmark score for all quality criteria, yet three pathologists only marginally failed the agreement with consensus diagnosis (score 68.3%, benchmark 69%). After a group discussion and phase II, 5/6 remaining aspirant panel members qualified with all scores within the benchmark range.

CONCLUSIONS

The Dutch BO review panel now consists of 14 pathologists, who-after structured assessments and group discussions-can be considered homogeneous in their review of biopsies with LGD.

摘要

目的

巴雷特食管(BO)中低级别异型增生(LGD)的组织病理学诊断一致性较差,指南建议进行专家审查。为了便于在荷兰进行全国性的专家审查,已经建立了一个基于网络的数字审查小组,目前由 8 名“核心”病理学家组成。本研究的目的是通过评估 80 例连续提交给小组的 LGD 病例的表现,评估荷兰 BO 专家中心的其他病理学家是否有资格成为专家小组成员。

方法

病理学家在两个阶段独立评估数字切片。两个阶段均包含 40 例病例,第一阶段后进行小组讨论。对于所有病例,均提供了 5 名核心病理学家的先前共识诊断作为参考。使用以下标准:(1)“不确定为异型增生”诊断的百分比,(2)与共识诊断的百分比一致性,以及(3)共识诊断为异型增生的病例中被误诊为非异型增生的比例。基准是基于核心病理学家的分数。

结果

第一阶段后,有 1/7 名病理学家满足所有质量标准的基准分数,但有 3 名病理学家仅在与共识诊断的一致性方面略有不足(分数 68.3%,基准 69%)。经过小组讨论和第二阶段,6 名剩余的候选小组成员中的 5 名获得了资格,所有分数均在基准范围内。

结论

荷兰 BO 审查小组现在由 14 名病理学家组成,他们在对具有 LGD 的活检进行审查时,可以通过结构化评估和小组讨论被认为是同质的。

相似文献

1
Performance of gastrointestinal pathologists within a national digital review panel for Barrett's oesophagus in the Netherlands: results of 80 prospective biopsy reviews.荷兰国家数字审查小组中胃肠道病理学家在 Barrett 食管中的表现:80 例前瞻性活检审查结果。
J Clin Pathol. 2021 Jan;74(1):48-52. doi: 10.1136/jclinpath-2020-206511. Epub 2020 May 28.
2
Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus.坚持预设的基准质量标准,有资格成为 Barrett 食管活检中不典型增生的专家评估者 - 迈向 Barrett 食管的数字审查。
United European Gastroenterol J. 2019 Aug;7(7):889-896. doi: 10.1177/2050640619853441. Epub 2019 May 21.
3
Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining.数字化 Barrett 食管活检的 p53 免疫组化染色可改善诊断分层。
Histopathology. 2018 May;72(6):1015-1023. doi: 10.1111/his.13462. Epub 2018 Feb 28.
4
Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists.巴雷特食管发育异常的分级:普通病理学家与胃肠病理学家之间存在显著的观察者间差异。
Histopathology. 2007 Jun;50(7):920-7. doi: 10.1111/j.1365-2559.2007.02706.x.
5
Digital microscopy as valid alternative to conventional microscopy for histological evaluation of Barrett's esophagus biopsies.数字显微镜作为传统显微镜的有效替代方法用于巴雷特食管活检的组织学评估。
Dis Esophagus. 2017 Nov 1;30(11):1-7. doi: 10.1093/dote/dox078.
6
The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.巴雷特食管低度发育异常的诊断及其对疾病进展的影响。
Am J Gastroenterol. 2000 Dec;95(12):3383-7. doi: 10.1111/j.1572-0241.2000.03348.x.
7
Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases.用于评估全内镜下巴雷特食管活检病例的基准质量标准的制定。
United European Gastroenterol J. 2018 Jul;6(6):830-837. doi: 10.1177/2050640618764710. Epub 2018 Mar 7.
8
Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus.美国和欧洲病理学家在诊断 Barrett 食管低级别异型增生患者中的分歧。
Gastroenterology. 2017 Feb;152(3):564-570.e4. doi: 10.1053/j.gastro.2016.10.041. Epub 2016 Nov 3.
9
Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.巴雷特食管低级别异型增生的诊断和管理:美国胃肠病学会临床实践更新委员会的专家综述。
Gastroenterology. 2016 Nov;151(5):822-835. doi: 10.1053/j.gastro.2016.09.040. Epub 2016 Oct 1.
10
Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett's dysplasia using digital pathology.利用数字病理学诊断 Barrett 异型增生的国际大样本病理学家中,组织病理学家特征可预测专家级别的诊断一致性。
Gut. 2020 May;69(5):811-822. doi: 10.1136/gutjnl-2019-318985. Epub 2019 Dec 18.

引用本文的文献

1
Dedicated service for Barrett's oesophagus surveillance endoscopy yields higher dysplasia detection and guideline adherence in a non-tertiary setting in the UK: a 5-year comparative cohort study.在英国的非三级医疗机构中,巴雷特食管监测内镜的专门服务在发育异常检测及指南遵循方面表现更佳:一项为期5年的比较队列研究。
Frontline Gastroenterol. 2023 Aug 10;15(1):21-27. doi: 10.1136/flgastro-2023-102425. eCollection 2024 Jan.
2
Real-world implementation of non-endoscopic triage testing for Barrett's oesophagus during COVID-19.COVID-19 期间 Barrett 食管非内镜分诊检测的真实世界实施。
QJM. 2023 Sep 12;116(8):659-666. doi: 10.1093/qjmed/hcad093.
3
Reproducibility and Feasibility of Classification and National Guidelines for Histological Diagnosis of Canine Mammary Gland Tumours: A Multi-Institutional Ring Study.犬乳腺肿瘤组织学诊断分类及国家指南的可重复性和可行性:一项多机构环形研究
Vet Sci. 2022 Jul 13;9(7):357. doi: 10.3390/vetsci9070357.
4
The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia.P53 免疫组化在诊断不明确的 Barrett 食管伴异型增生中的应用。
Histopathology. 2022 Jun;80(7):1081-1090. doi: 10.1111/his.14642.
5
Impact of expert center endoscopic assessment of confirmed low grade dysplasia in Barrett's esophagus diagnosed in community hospitals.社区医院诊断的巴雷特食管伴固有性低级别上皮内瘤变的专家中心内镜评估的影响。
Endoscopy. 2022 Oct;54(10):936-944. doi: 10.1055/a-1754-7309. Epub 2022 Jan 28.
6
Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot.使用 Cytosponge 生物标志物面板对内镜 Barrett 食管监测进行优先级排序:一项横断面研究及后续真实世界前瞻性试点研究。
Lancet Oncol. 2022 Feb;23(2):270-278. doi: 10.1016/S1470-2045(21)00667-7. Epub 2022 Jan 11.

本文引用的文献

1
Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus.坚持预设的基准质量标准,有资格成为 Barrett 食管活检中不典型增生的专家评估者 - 迈向 Barrett 食管的数字审查。
United European Gastroenterol J. 2019 Aug;7(7):889-896. doi: 10.1177/2050640619853441. Epub 2019 May 21.
2
Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases.用于评估全内镜下巴雷特食管活检病例的基准质量标准的制定。
United European Gastroenterol J. 2018 Jul;6(6):830-837. doi: 10.1177/2050640618764710. Epub 2018 Mar 7.
3
Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining.数字化 Barrett 食管活检的 p53 免疫组化染色可改善诊断分层。
Histopathology. 2018 May;72(6):1015-1023. doi: 10.1111/his.13462. Epub 2018 Feb 28.
4
Digital microscopy as valid alternative to conventional microscopy for histological evaluation of Barrett's esophagus biopsies.数字显微镜作为传统显微镜的有效替代方法用于巴雷特食管活检的组织学评估。
Dis Esophagus. 2017 Nov 1;30(11):1-7. doi: 10.1093/dote/dox078.
5
Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia.英国胃肠病学会关于低度异型增生巴雷特食管诊断和管理的修订建议。
Gut. 2018 Feb;67(2):392-393. doi: 10.1136/gutjnl-2017-314135. Epub 2017 Apr 7.
6
Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.内镜下 Barrett 食管的处理:欧洲胃肠道内镜学会(ESGE)立场声明。
Endoscopy. 2017 Feb;49(2):191-198. doi: 10.1055/s-0042-122140. Epub 2017 Jan 25.
7
Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.患有巴雷特食管且证实存在持续低度异型增生的患者发生肿瘤进展的风险增加。
Gastroenterology. 2017 Apr;152(5):993-1001.e1. doi: 10.1053/j.gastro.2016.12.008. Epub 2016 Dec 22.
8
Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.巴雷特食管低级别异型增生的诊断和管理:美国胃肠病学会临床实践更新委员会的专家综述。
Gastroenterology. 2016 Nov;151(5):822-835. doi: 10.1053/j.gastro.2016.09.040. Epub 2016 Oct 1.
9
What Makes an Expert Barrett's Histopathologist?如何成为一名专业的巴雷特食管组织病理学家?
Adv Exp Med Biol. 2016;908:137-59. doi: 10.1007/978-3-319-41388-4_8.
10
ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.美国胃肠病学会临床指南:巴雷特食管的诊断与管理
Am J Gastroenterol. 2016 Jan;111(1):30-50; quiz 51. doi: 10.1038/ajg.2015.322. Epub 2015 Nov 3.